Endovascular manipulation to restrict restenosis

Area of Science:

• Vascular biology
• Interventional cardiology
• Biomaterials science

Background:

• Endovascular procedures inherently cause vessel wall damage, leading to restenosis and symptom recurrence.
• Previous clinical trials using systemic drugs to prevent this response have largely failed due to low effective doses and side effects.
• Local drug delivery presents an alternative to achieve high, targeted drug concentrations at the site of injury.

Purpose of the Study:

• To review the potential of local drug delivery strategies for mitigating adverse vessel wall responses post-endovascular manipulation.
• To discuss various drugs and delivery methods being investigated for their efficacy in preventing neointimal hyperplasia and restenosis.

Main Methods:

• Review of existing literature on vessel wall repair mechanisms and the impact of endovascular interventions.
• Analysis of preclinical data on drugs (e.g., heparin, nitric oxide, platelet inhibitors, antisense oligonucleotides) and delivery systems.
• Examination of novel approaches like drug-eluting stents and localized radiation delivery.

Main Results:

• Preclinical studies show efficacy of various agents and local delivery methods in reducing vessel wall proliferation.
• Stents are being repurposed as local drug delivery devices, with drug-eluting stents and radiation delivery showing promise.
• Clinical trial results for local drug delivery in humans are still pending.

Conclusions:

• Local drug delivery holds significant promise for reducing adverse vessel wall responses after endovascular procedures.
• Further clinical trials are necessary to validate the efficacy and safety of these advanced local delivery strategies.
• Optimizing drug selection and delivery systems is crucial for successful clinical translation.